Difference between revisions of "Team:BostonU"

Line 1: Line 1:
 +
 
<html>
 
<html>
 
<head>
 
<head>
 
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
 
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
 
<title>Boston University IGEM 2015</title>
 
<title>Boston University IGEM 2015</title>
−
      
+
 
 +
     <style type="text/css">
 +
        @charset "utf-8";
 +
* {
 +
margin: 0px; padding: 0px;
 +
}
 +
.clear {
 +
clear:both;}
 +
.clearleft {
 +
display:block;
 +
clear:left;}
 +
.clearright{
 +
display:block;
 +
clear:right;}
 +
.hide {
 +
display:none;}
 +
a {
 +
color:#B32C0E;
 +
}
 +
 
 +
a:hover {
 +
color:#000000;
 +
text-decoration:none;
 +
}
 +
body {
 +
background: #FFFFFF  url(images/bg.jpg) repeat-x;
 +
}
 +
#wrap {
 +
    width: 100%;
 +
    margin: 0px auto 15px auto;
 +
    font-family: Verdana, Arial, Helvetica, sans-serif;
 +
    font-size: 12px;
 +
    color: #666666;
 +
}
 +
 
 +
/*Header*/
 +
 
 +
#header {
 +
 +
    height: 265px;
 +
    background: url(homepic.jpg) no-repeat;
 +
    background-repeat: no-repeat;
 +
    background-position: center;
 +
}
 +
/*Header Menu*/
 +
#topmenu {
 +
    display: block;
 +
    list-style: none;
 +
    padding: 0 0px 0px 0px;
 +
}
 +
#topmenu li {
 +
display:inline;
 +
}
 +
#topmenu a {
 +
    display: block;
 +
    float: left;
 +
    height: 28px;
 +
    margin: 0px 0px 0px 0px;
 +
    text-decoration: none;
 +
    padding: 9px 15px 0px 15px;
 +
    text-align: center;
 +
    font-family: calibri;
 +
    font-size: 15px;
 +
    font-weight: bold;
 +
}
 +
#topmenu a, #topmenu a:visited, #topmenu a:active {
 +
color:#FFFFFF;
 +
}
 +
#topmenu a:hover{
 +
color:#ffffff;
 +
background-color: #B52E10;
 +
}
 +
#topmenu .active a, #topmenu .active a:visited, #topmenu .active a:active{
 +
color:#FFFFFF;
 +
background-color: #B42D0F;
 +
}
 +
 
 +
/*Content*/
 +
#content {
 +
    border-color: #C0C0C0;
 +
    background-color: #FFFFFF;
 +
    width: 80%;
 +
    margin-right: auto;
 +
    margin-left: auto;
 +
    border-radius: 10px;
 +
    font-weight: bold;
 +
    font-size: 16px;
 +
}
 +
#mainpage {
 +
    border: 1px solid #C0C0C0;
 +
    width: 100%;
 +
    float: left;
 +
    padding: 10px;
 +
    height: 300px;
 +
    box-shadow: 5px 5px 2px #888888;
 +
    border-radius: 10px;
 +
    background-color: #F0F0F0;
 +
    font-family: 'Calibri Light';
 +
}
 +
#mainpage p {
 +
line-height:22px;
 +
margin:10px 0px 22px 0px;
 +
}
 +
#mainpage blockquote {
 +
background:#efefef;
 +
display:block;
 +
margin:5px;
 +
font:Georgia, "Times New Roman", Times, serif;
 +
font-style:italic;}
 +
h2, h3, h4, h5 {
 +
    color: #B32C0E;
 +
    font-weight: bold;
 +
    font-family: Arial, Helvetica, sans-serif;
 +
    vertical-align: middle;
 +
    font-size: 30px;
 +
}
 +
h1 {
 +
    color: #B32C0E;
 +
    font-weight: bold;
 +
    font-family: Calibri;
 +
    height: 59px;
 +
    vertical-align: middle;
 +
    line-height: 60px;
 +
    font-size: 30px;
 +
    width: 962px;
 +
    float: left;
 +
}
 +
 
 +
 
 +
#mainpage h1 {
 +
font-size:24px;
 +
color: #F2F7F3;
 +
}
 +
#mainpage h2 {
 +
font-size:20px;
 +
padding-top: 20px;
 +
padding-bottom: 5px;
 +
border-bottom: 1px solid #B52E10;
 +
}
 +
#mainpage h3 {
 +
font-size:20px;}
 +
#mainpage h4 {
 +
font-size:18px;}
 +
#mainpage h5 {
 +
font-size:16px;}
 +
.style_2 {
 +
font-size: 7px;
 +
color: #000011;
 +
}
 +
.style_2 a{
 +
font-size: 7px;
 +
color: #000011;
 +
}
 +
.style_2 a:hover{
 +
font-size: 7px;
 +
color: #000011;
 +
}
 +
#content #mainpage ol {
 +
margin:10px 10px 10px 25px;}
 +
#content #mainpage ol li {
 +
padding:5px 5px 5px 20px;}
 +
#content #mainpage ul li {
 +
display:block;
 +
padding:0px;
 +
border-bottom: dashed 1px #D6E4A7;}
 +
 
 +
 
 +
 
 +
 
 +
/*Sidebar*/
 +
#sidebar {
 +
margin:0px 0px 0px 0px;
 +
width: 225px;
 +
float: right;
 +
}
 +
#sidebarcontents {
 +
padding:5px 0px 5px 0px;
 +
}
 +
 
 +
/*Sidemenu*/
 +
#menu {
 +
list-style:none;
 +
}
 +
#menu li ul {list-style:none;}
 +
#menu li ul li {
 +
display:block;
 +
height:25px;
 +
border-bottom:solid 1px #efefef;}
 +
#menu li ul a, #menu li ul a:visited, #menu li ul a:active {
 +
display:block;
 +
height:20px;
 +
padding:5px 5px 0px 5px;
 +
text-decoration:none;
 +
color:#333333;}
 +
#menu li ul  a:hover {
 +
background:#F8F9F2;
 +
color:#B32C0E;
 +
}
 +
#menu h2 {
 +
display:block;
 +
border-bottom:solid 1px #D2E6CA;
 +
padding:5px;
 +
margin:10px 0px 0px 0px;
 +
font-family: Arial, Helvetica, sans-serif;
 +
font-size:18px;
 +
color:#B32C0E;
 +
font-weight:bold;
 +
}
 +
 
 +
/*footer*/
 +
#footer {
 +
    margin: 20px auto 0 auto;
 +
    width: 98.2%;
 +
    height: 60px;
 +
    padding: 10px;
 +
    color: #FFFFFF;
 +
    text-align: center;
 +
    background: #333333;
 +
    font-family: Verdana, Arial, Helvetica, sans-serif;
 +
    font-size: 11px;
 +
    clear: both;
 +
}
 +
#credit {font-size:10px;
 +
padding:3px;}
 +
#sitename a {
 +
    text-decoration: none;
 +
 
 +
    vertical-align: middle;
 +
    float: left;
 +
    height: 41px;
 +
}
 +
#topbar {
 +
    height: 116px;
 +
    background-color: #333333;
 +
}
 +
#caption{
 +
height:50px;
 +
background:url(images/caption.gif) repeat-x top left;
 +
}
 +
.bold{font-size:16px;
 +
color:#FFFFFF;
 +
padding-left:100px;
 +
padding-top:25px;
 +
}
 +
.headername {
 +
    padding: 10px;
 +
    height: 58px;
 +
    vertical-align: middle;
 +
    background-color: #FFFFFF;
 +
    color: #800000;
 +
}
 +
.headericon {
 +
    float: left;
 +
    width: 90px;
 +
    height: 60px;
 +
}
 +
.igemicon {
 +
    float: right;
 +
    width: 100px;
 +
    height: 60px;
 +
    margin-right: 15px;
 +
}
 +
 
  
 +
    </style>
 
      
 
      
  

Revision as of 09:56, 30 July 2015

Boston University IGEM 2015


Welcome to Our Project !

The goal of our team this summer is to create an efficient and widely applicable workflow for splitting proteins. By splitting proteins and fusing each half to a drug-inducible domain, scientists can gain temporal control over protein expression. Using our workflow, the proteins will be translated into two inert halves that are each fused to domains that bind in the presence of an inducer drug. By introducing the drug into the system, the two inert protein halves will come together and for a fully functioning protein. In this way, scientists can further increase their control over protein function. The two types of proteins we will be testing our workflow on are the large serine integrase family and saCAS9. These proteins harness powerful mechanisms that have significant applications in the future of synthetic biology. By using our workflow, we hope to increase scientists understanding of these proteins and also provide a mechanism for increasing temporal control.